Table 2 Summary of antibodies which can be used in differential diagnosis of ACA and SCC
From: Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases
| ACA | SCC | |
|---|---|---|
| HNF-1β | ++ | - |
| (75%) | (2%) | |
| p63/p40 | −+ | +++ |
| (7% / 4%) | (100%) | |
| CEA | +++ | +++ |
| (86%) | (91%) | |
| ER | +− | +− |
| (16%) | (11%) | |
| PR | −+ | - |
| (9%) | (1%) | |
| D2-40 | - | ++ |
| (0%) | (54%) |
